☰

Tarek A. Abbas, Ph.D. - Publications

Affiliations: 
2004 City University of New York, New York, NY, United States 
Area:
Molecular Biology
Tree Info Similar researchers PubMed Report error

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Genetta TL, Hurwitz JC, Clark EA, Herold BT, Khalil S, Abbas T, Larner JM. ZEB1 promotes non-homologous end joining double-strand break repair. Nucleic Acids Research. PMID 37665026 DOI: 10.1093/nar/gkad723  0.36
2021 Paulsen T, Malapati P, Shibata Y, Wilson B, Eki R, Benamar M, Abbas T, Dutta A. MicroDNA levels are dependent on MMEJ, repressed by c-NHEJ pathway, and stimulated by DNA damage. Nucleic Acids Research. 49: 11787-11799. PMID 34718766 DOI: 10.1093/nar/gkab984  0.447
2021 Banerjee D, Langberg K, Abbas S, Odermatt E, Yerramothu P, Volaric M, Reidenbach MA, Krentz KJ, Rubinstein CD, Brautigan DL, Abbas T, Gelfand BD, Ambati J, Kerur N. A non-canonical, interferon-independent signaling activity of cGAMP triggers DNA damage response signaling. Nature Communications. 12: 6207. PMID 34707113 DOI: 10.1038/s41467-021-26240-9  0.389
2020 Eki R, She J, Parlak M, Benamar M, Du KP, Kumar P, Abbas T. A robust CRISPR-Cas9-based fluorescent reporter assay for the detection and quantification of DNA double-strand break repair. Nucleic Acids Research. PMID 33068408 DOI: 10.1093/nar/gkaa897  0.377
2020 Abbas T. The Role of Ubiquitination and SUMOylation in DNA Replication. Current Issues in Molecular Biology. 40: 189-220. PMID 32606249 DOI: 10.21775/Cimb.040.189  0.48
2020 Jang Y, Elsayed Z, Eki R, He S, Du KP, Abbas T, Kai M. Intrinsically disordered protein RBM14 plays a role in generation of RNA:DNA hybrids at double-strand break sites. Proceedings of the National Academy of Sciences of the United States of America. PMID 32094185 DOI: 10.1073/Pnas.1913280117  0.451
2018 Olmez I, Zhang Y, Manigat L, Benamar M, Brenneman B, Nakano I, Godlewski J, Bronisz A, Lee J, Abbas T, Abounader R, Purow B. Combined c-Met/Trk inhibition overcomes resistance to CDK4/6 inhibitors in Glioblastoma. Cancer Research. PMID 29844123 DOI: 10.1158/0008-5472.Can-17-3124  0.381
2017 Abbas T, Dutta A. Regulation of Mammalian DNA Replication via the Ubiquitin-Proteasome System. Advances in Experimental Medicine and Biology. 1042: 421-454. PMID 29357069 DOI: 10.1007/978-981-10-6955-0_19  0.547
2017 Vanderdys V, Allak A, Guessous F, Benamar M, Read PW, Jameson MJ, Abbas T. The Neddylation Inhibitor Pevonedistat (MLN4924) Suppresses and Radiosensitizes Head and Neck Squamous Carcinoma Cells and Tumors. Molecular Cancer Therapeutics. PMID 28838998 DOI: 10.1158/1535-7163.Mct-17-0083  0.479
2017 Olmez I, Brenneman B, Xiao A, Serbulea V, Benamar M, Zhang Y, Manigat L, Abbas T, Lee J, Nakano I, Godlewski J, Bronisz A, Abounader R, Leitinger N, Purow B. Combined CDK4/6 and mTOR inhibition is synergistic against glioblastoma via multiple mechanisms. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28814434 DOI: 10.1158/1078-0432.Ccr-17-0803  0.379
2017 Yang CS, Jividen K, Spencer A, Dworak N, Ni L, Oostdyk LT, Chatterjee M, Kuśmider B, Reon B, Parlak M, Gorbunova V, Abbas T, Jeffery E, Sherman NE, Paschal BM. Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9. Molecular Cell. 66: 503-516.e5. PMID 28525742 DOI: 10.1016/J.Molcel.2017.04.028  0.402
2017 Biswas K, Sarkar S, Du K, Brautigan DL, Abbas T, Larner JM. The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance. Molecular Cancer Research : McR. PMID 28232384 DOI: 10.1158/1541-7786.Mcr-16-0466  0.451
2016 Benamar M, Guessous F, Du K, Corbett P, Obeid J, Gioeli D, Slingluff CL, Abbas T. Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma. Ebiomedicine. PMID 27333051 DOI: 10.1016/J.Ebiom.2016.06.023  0.544
2015 Heo J, Eki R, Abbas T. Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis. Seminars in Cancer Biology. PMID 26432751 DOI: 10.1016/J.Semcancer.2015.09.015  0.318
2015 Guessous F, Heo J, Vaddadi N, Abbas T. Abstract 3786: Novel regulation of cyclin D1 stability and the DNA damage response Cancer Research. 75: 3786-3786. DOI: 10.1158/1538-7445.Am2015-3786  0.434
2015 Benamar M, Guessous F, Corbett P, Slingluff CL, Abbas T. Abstract 1780: Targeted inactivation of CRL4-CDT2 E3 ubiquitin ligase as a novel therapeutic strategy for malignant melanoma Cancer Research. 75: 1780-1780. DOI: 10.1158/1538-7445.Am2015-1780  0.401
2014 Sekhar KR, Benamar M, Venkateswaran A, Penthala NR, Crooks PA, Hann SR, Geng L, Balusu R, Abbas T, Freeman ML. Abstract 4905: Targeting NPM1 for the radiosensitization of NSCLC Cancer Research. 74: 4905-4905. DOI: 10.1158/1538-7445.Am2014-4905  0.427
2013 Terai K, Shibata E, Abbas T, Dutta A. Degradation of p12 subunit by CRL4Cdt2 E3 ligase inhibits fork progression after DNA damage. The Journal of Biological Chemistry. 288: 30509-14. PMID 24022480 DOI: 10.1074/Jbc.C113.505586  0.609
2013 Abbas T, Keaton M, Dutta A. Regulation of TGF-β signaling, exit from the cell cycle, and cellular migration through cullin cross-regulation: SCF-FBXO11 turns off CRL4-Cdt2. Cell Cycle (Georgetown, Tex.). 12: 2175-82. PMID 23892434 DOI: 10.4161/Cc.25314  0.469
2013 Abbas T, Mueller AC, Shibata E, Keaton M, Rossi M, Dutta A. CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration. Molecular Cell. 49: 1147-58. PMID 23478445 DOI: 10.1016/J.Molcel.2013.02.003  0.391
2013 Park J, Long DT, Lee KY, Abbas T, Shibata E, Negishi M, Luo Y, Schimenti JC, Gambus A, Walter JC, Dutta A. The MCM8-MCM9 complex promotes RAD51 recruitment at DNA damage sites to facilitate homologous recombination. Molecular and Cellular Biology. 33: 1632-44. PMID 23401855 DOI: 10.1128/Mcb.01503-12  0.536
2013 Abbas T, Keaton MA, Dutta A. Genomic instability in cancer. Cold Spring Harbor Perspectives in Biology. 5: a012914. PMID 23335075 DOI: 10.1101/Cshperspect.A012914  0.477
2011 Van Rechem C, Black JC, Abbas T, Allen A, Rinehart CA, Yuan GC, Dutta A, Whetstine JR. The SKP1-Cul1-F-box and leucine-rich repeat protein 4 (SCF-FbxL4) ubiquitin ligase regulates lysine demethylase 4A (KDM4A)/Jumonji domain-containing 2A (JMJD2A) protein. The Journal of Biological Chemistry. 286: 30462-70. PMID 21757720 DOI: 10.1074/Jbc.M111.273508  0.357
2011 Shibata E, Abbas T, Huang X, Wohlschlegel JA, Dutta A. Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex. Molecular and Cellular Biology. 31: 3136-45. PMID 21628527 DOI: 10.1128/Mcb.05496-11  0.554
2011 Abbas T, Dutta A. CRL4Cdt2: master coordinator of cell cycle progression and genome stability. Cell Cycle (Georgetown, Tex.). 10: 241-9. PMID 21212733 DOI: 10.4161/Cc.10.2.14530  0.438
2011 Ring KE, Abbas T, Bryant J, Dutta A, Jazaeri AA. Abstract 608: Oncogenic role of cullin 4 E3 ubiquitin ligase (CRL4-CDT2) in epithelial ovarian cancer Cancer Research. 71: 608-608. DOI: 10.1158/1538-7445.Am2011-608  0.391
2010 Abbas T, Shibata E, Park J, Jha S, Karnani N, Dutta A. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Molecular Cell. 40: 9-21. PMID 20932471 DOI: 10.1016/J.Molcel.2010.09.014  0.425
2010 Terai K, Abbas T, Jazaeri AA, Dutta A. CRL4(Cdt2) E3 ubiquitin ligase monoubiquitinates PCNA to promote translesion DNA synthesis. Molecular Cell. 37: 143-9. PMID 20129063 DOI: 10.1016/J.Molcel.2009.12.018  0.541
2009 Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nature Reviews. Cancer. 9: 400-14. PMID 19440234 DOI: 10.1038/Nrc2657  0.478
2008 Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes & Development. 22: 2496-506. PMID 18794347 DOI: 10.1101/Gad.1676108  0.59
2007 Abbas T, Jha S, Sherman NE, Dutta A. Autocatalytic phosphorylation of CDK2 at the activating Thr160. Cell Cycle (Georgetown, Tex.). 6: 843-52. PMID 17361108 DOI: 10.4161/Cc.6.7.4000  0.365
2006 Sivaprasad U, Abbas T, Dutta A. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells. Molecular Cancer Therapeutics. 5: 2310-6. PMID 16985065 DOI: 10.1158/1535-7163.Mct-06-0175  0.376
2006 Abbas T, Dutta A. CDK2-activating kinase (CAK): more questions than answers. Cell Cycle (Georgetown, Tex.). 5: 1123-4. PMID 16687928 DOI: 10.4161/Cc.5.10.2819  0.379
2005 Zhu W, Abbas T, Dutta A. DNA replication and genomic instability. Advances in Experimental Medicine and Biology. 570: 249-79. PMID 18727504 DOI: 10.1007/1-4020-3764-3_9  0.406
2004 Hui L, Abbas T, Pielak RM, Joseph T, Bargonetti J, Foster DA. Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53. Molecular and Cellular Biology. 24: 5677-86. PMID 15199126 DOI: 10.1128/Mcb.24.13.5677-5686.2004  0.72
2004 Abbas T, White D, Hui L, Yoshida K, Foster DA, Bargonetti J. Inhibition of human p53 basal transcription by down-regulation of protein kinase Cdelta. The Journal of Biological Chemistry. 279: 9970-7. PMID 14699137 DOI: 10.1074/Jbc.M306979200  0.694
2002 Abbas T, Olivier M, Lopez J, Houser S, Xiao G, Kumar GS, Tomasz M, Bargonetti J. Differential activation of p53 by the various adducts of mitomycin C. The Journal of Biological Chemistry. 277: 40513-9. PMID 12183457 DOI: 10.1074/Jbc.M205495200  0.529
Show low-probability matches.